Latest Operational Scalability News

NobleOak Life delivered robust FY26 results with in-force premiums climbing 18% to $549.2 million and underlying NPAT up 15%, driven by strong market share gains and operational efficiency.

RAS Technology Holdings (ASX:RTH) posted a 34% revenue increase to $28.4 million for FY2026, driven by expansion across all business units and geographic markets including Asia and the UK. Despite this, significant investments in product development and trading capabilities led to a normalized net loss after tax of $0.3 million.

EVZ Limited reported a 14% revenue increase to $123.1 million and a 213% jump in net profit after tax to $3.87 million for FY2026, resuming dividends for the first time since 2010.

WT Financial Group (ASX: WTL) delivered its sixth consecutive year of growth in FY2026, with net profit before tax up 19% to $6.55 million and a fully franked final dividend declared at 0.75 cents per share. The company also completed a strategic disposal of its B2C subsidiaries, advancing its Hubco investment model.

SCX.ai Holdings Limited is set to raise $40 million through a fully underwritten IPO at $0.30 per share, aiming to scale its sovereign AI inferencing platform built on ASIC hardware within Australian data centres. The company targets the fast-growing AI IaaS market with a focus on secure, low-latency AI workloads.

N1 Holdings delivered a record quarter for settlement volumes and cash receipts despite a tough interest rate environment, driving a 10% rise in FY26 revenue to $21.67 million and $1.21 million net profit before tax.

Adheris Health’s revenue and profit fell sharply in Q4 FY26 due to the previous challenging pharma budget cycle, but the company achieved cashflow break-even and ended the period with $9.5 million in net cash.

Boss Energy has delivered on its revised FY26 uranium production guidance with 1.41 million pounds of U3O8 and accelerated its feasibility study for the Honeymoon project, aiming to unlock future growth with a new life-of-mine plan by August 2026.

Neurizon Therapeutics has secured a critical five-year supply agreement with Elanco Animal Health for GMP-grade monepantel, underpinning the commercialisation readiness of its lead ALS drug candidate NUZ-001.

Smartgroup posted robust 2025 results with record customer growth and accelerated EV leasing, backed by strategic digital investments and a $20 million share buy-back plan following fleet portfolio sales.

Anson Resources and POSCO Holdings have sealed a binding deal for a $7.2 million lithium extraction demonstration plant at Green River, advancing the project from concept to operational validation.

Aquirian Limited has secured $8 million through a strongly supported placement to accelerate growth of its Drillforce business and support a major $48 million contract at the Lord Byron mine.